Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial (Q44513878)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial |
scientific article |
Statements
1 reference
Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial (English)
1 reference
John Fr Robertson
1 reference
Jean-Marc Ferrero
1 reference
Hugues Bourgeois
1 reference
Hagen Kennecke
1 reference
Richard H de Boer
1 reference
William Jacot
1 reference
Jesse McGreivy
1 reference
Samuel Suzuki
1 reference
Min Zhu
1 reference
Ian McCaffery
1 reference
Elwyn Loh
1 reference
Jennifer L Gansert
1 reference
Peter A Kaufman
1 reference
13 February 2013
1 reference
1 reference
Identifiers
1 reference